In this article, we explore the 10 Best Performing ASX Stocks in 2025.
Australian equities have delivered strong returns in 2025. The S&P/ASX 200 Index is up 7.15% year-to-date, and about 20% above the April 7 slump. Australia, like many other countries that trade with the US, has suffered from President Donald Trump’s tariff policies. In fact, Oxford Economics placed the blame at the tariffs’ door when predicting that Australia’s GDP will “remain subdued at 1.8%” in 2025.
Despite the headwinds, the average Australian investor is quite bullish. Findings from the Australian Shareholders’ Association (ASA) Investor Sentiment Survey indicate that over 60% are somewhat or very confident in the sharemarket. Nothing demonstrates this bullishness better than individual stock performances; several Australian Stock Exchange (ASX) companies have posted triple-digit gains throughout the year. According to IG Australian analysts, growth shares in technology and defense-related stocks “have delivered exceptional returns.” Several sectors have pulled ahead: in June alone, energy grew 9.0%, financials upped 4.3%, and communications increased by 1.6%, outpacing weaker showings in materials and consumer staples. At the same time, analysts point to improved global trade dynamics and supportive domestic policies as key underpinnings that will propel Australian stocks in the remainder of 2025.
With that context, some ASX-listed companies, which are available to US investors, have stood out with exceptional performance. This article highlights the best 10.
Our Methodology
To identify the 10 best-performing ASX stocks in 2025, we used the Finviz stock screener and market data from Yahoo Finance, supplemented with insights from other reputable financial platforms. Our focus was on stocks with only those showing positive year-to-date returns as of September 26, 2025, making the cut. We then incorporated institutional ownership trends from Insider Monkey’s Q2 2025 hedge fund database. The final ranking is presented in ascending order based on year-to-date performance.
Why are we interested in the stocks that hedge funds pile into? The reason is straightforward: our research has demonstrated that we can outperform the market by replicating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
Best Performing ASX Stocks in 2025
10. Immuron Limited (NASDAQ:IMRN)
Year-To-Date Returns: 13.53%
Number of Hedge Fund Holders: N/A
Immuron Limited (NASDAQ:IMRN) is one of the best performing ASX stocks in 2025. The company released its annual report for 2025 on September 25, in which it reported a 49% growth in global revenue for fiscal year 2025. It stated that much of the growth was due to robust sales of its flagship traveler’s diarrhea product, Travelan. North American sales for Travelan increased by 76% to A$2 million, attributed to Amazon and Canadian retail growth. Australian sales rose 40% to AU$5.3 million, aided by new pharmacy channels.
The company’s net loss for the financial year reduced 24% year-over-year to AU$5.25 million. And loss per share was also better than FY2024’s: A$0.023 for FY2025, compared to AU$0.03. Gross margins for the year remained robust at 65.4%. At year-end, Immuron held AU$2.83 million in cash, down from AU$11.66 million the previous year. Shareholders’ equity stood at AU$8 million, compared to AU$12.7 million in 2024. And there was no significant long-term debt on the balance sheet; total debt remained minimal.
Immuron Limited (NASDAQ:IMRN) is one of Australia’s largest biopharmaceutical companies. It specializes in orally delivered targeted polyclonal antibodies for gastrointestinal and infectious diseases. Its flagship product is Travelan.
9. BHP Group Limited (NYSE:BHP)
Year-To-Date Returns: 14.05%
Number of Hedge Fund Holders: 29
BHP Group Limited (NYSE:BHP) is one of the best performing ASX stocks in 2025. On September 16, BHP Mitsubishi Alliance (BMA) – a joint venture between BHP and Mitsubishi Development – said it will cut 750 jobs across Queensland. BMA will also suspend operations at the Saraji South coking coal mine. The joint venture will place the Saraji South site into care and maintenance, starting in November 2025, effectively halting active mining at that location. Of the 750 jobs, direct coal production jobs affected at Saraji South will number around 72. The remainder impacts corporate and broader support staff across Queensland operations.
BMA attributes its decision to two key factors: high Queensland state royalties on coal sales and soft global coking coal prices. The company’s President, Adam Lancey, stated the decision was “necessary” due to the combined impact of “the Queensland government’s unsustainable coal royalties and market conditions.” He added, “As joint owners of BMA, BHP and Mitsubishi Development regret the necessity of pausing operations and the resulting job losses, but these decisions are vital”. The Queensland government recently reiterated that it would maintain the royalty regime and not consider lowering the charges.
BHP Group Limited (NYSE:BHP) is the world’s largest diversified mining company. It produces iron ore, copper, coal, and nickel, with major operations in Australia and the Americas.
Hedge Fund Resource Center